Teresa Brophy Bair, Chief Legal Officer at Kura Oncology, Inc. (KURA), sold 2,256 shares at $9.38 ($21K) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Scheduled sale ($21k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KURA | SELL | 2026-01-27 | $95K | — | Filing → |
| KURA | SELL | 2025-11-14 | $197K | — | Filing → |
| KURA | SELL | 2025-09-29 | $157K | — | Filing → |